Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Cancer Institute’s Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. Previously, he provided technical and strategic expertise to The Conafay Group, a Washington DC-based government affairs firm – leading efforts on non-dilutive funding and alliance development. Previously, he was a key member of the business development team for the healthcare practice at SAIC, a Fortune-500 government contractor. He helped lead and deepen relationships with the Department of Health and Human Services – especially NIH and FDA – as well as foundations and patient advocacy groups. Before SAIC, he was a long-time industry executive who has held various positions in early-stage biotechnology and boutique professional service firms. In addition, Dr. Salgaller was on the investment team of Toucan Capital, a $120M early-stage venture firm dedicated to the life sciences, where he guided company formation and helped raise follow-on financing. He began his career as a Senior Staff Scientist with Dr. Steve Rosenberg at the National Cancer Institute, where he oversaw a lab developing immunotherapies for patients with terminal cancer. He is the author of "Biotechnology Entrepreneurship," and teaches a NIH course on the subject. He is the author of >100 articles, book chapters, and abstracts.